Phosphoinositide-3 Kinase Inhibitors

Name
Phosphoinositide-3 Kinase Inhibitors
Accession Number
DBCAT005566
Description

Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity.

Drugs
DrugDrug Description
TenalisibTenalisib is under investigation in clinical trial NCT03711604 (Compassionate Use Study of Tenalisib (RP6530)).
InavolisibInavolisib (GDC-0077) is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine...
Drugs & Drug Targets
DrugTargetType